Advanced Physician Solutions Recalls Nanpyridoxine Injectable Due to Sterility Concerns
Advanced Physician Solutions is recalling Nanpyridoxine (Sterile Water) 30ml 50mg/ml injectable vials because the product lacks assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable product, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
Advanced Physician Solutions, Inc. is recalling Nanpyridoxine (Sterile Water) 30ml 50mg/ml injectable vials. The recall is being conducted because the product lacks assurance of sterility. The affected product is distributed nationwide and includes all lots.
The recall involves 30 vials of the injectable solution. The product was manufactured by Advanced Compounding Pharmacy located in North Hollywood, California. No specific dates or additional distribution details are provided in the source text.
Consumers and healthcare providers should stop using the recalled product and contact Advanced Physician Solutions, Inc. for further instructions or a refund. The FDA classifies this recall as Class II, indicating a reasonable probability of temporary or medically reversible adverse health consequences.
The recalled product
- Product
- NANPYRIDOXINE (STERILE WATER) 30ML 50MG/ML INJECTABLE,Advanced Compounding Pharmacy, 7225 Fulton Ave., North Hollywood, CA 91605
- Manufacturer
- Advanced Physician Solutions, Inc.
- Category
- Drug — Injectable
- Affected units
- 30
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Advanced Physician Solutions, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Advanced Physician Solutions, Inc.
See all →- SevereAdvanced Compounding Pharmacy Recalls Glycerin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Injectable Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Sodium Hyaluronate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereAdvanced Physician Solutions Recalls Sodium Hyaluronate Vials Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharm D Solutions Recalls Pyridoxine Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereAdvanced Pharma Recalls Phenylephrine HCl Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- SeverePharm D Solutions Recalls Trimix Injection Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereAssurance Infusion Recalls Alprostadil Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereApothecary NAD+ Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14
- SevereAdvanced Pharma Recalls Phenylephrine Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-03-27